Marker Therapeutics logo
Marker Therapeutics MRKR
$ 3.0 -5.66%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Marker Therapeutics Financial Ratios 2011-2024 | MRKR

Annual Financial Ratios Marker Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.5 -0.2 -3.1 -5.7 -0.7 -3.2 -11.8 -0.8 -0.1 -0.4 -1.8 -3.6

P/S

1.8 5.9 192.8 573.1 512.5 - - - - - - -

EPS

-3.6 -5.5 -0.6 -0.5 -7.8 -1.2 -0.4 -9.3 -2 -4.9 -9.4 -0.0

EV (Enterprise Value)

19.2 M -10.9 M 86.9 M 80.5 M 46.6 M 31.5 M 22.8 M 47.4 M 3.89 M 11.1 M 16.2 M 10.9 M

EBITDA per Share

-3.25 -4.88 -0.593 -0.488 -7.76 -1.27 -1.2 -1.68 -2.62 -28.1 -102 -68.8

EV/EBITDA

0.5 -2.5 -3.5 -0.3 -2.5 -2.6 -3.2 -0.8 -2.1 -2.1 -3.1

PEG

-0.0 -0.0 0.11 -0.06 0.0 0.01 -0.12 -0.01 -0.0 -0.01 0.01 -0.05

P/B

0.8 0.2 3.3 2.8 1.8 9.6 4.7 -1.2 -2.7 -0.3 -1.9 -2.1

P/CF

-0.6 -0.3 -3.1 -6.5 -7.2 -4.2 -4.4 -6.0 -1.3 -3.3 -6.7 -5.6

ROE %

-152.70 -95.21 -104.98 -48.60 -249.34 -300.21 -39.70 159.48 3017.00 63.10 103.38 58.63

ROA %

-86.95 -61.46 -62.93 -46.22 -238.09 -211.99 -31.00 -512.63 -13759.58 -7182.15 -5621.18 -596.38

ROCE %

-112.41 -71.47 -73.66 -50.78 -249.70 -313.82 -133.58 28.83 329.31 30.39 96.67 76.20

Current Ratio

2.3 2.8 3.8 22.8 22.1 3.4 4.6 0.2 0.2 0.0 0.0 0.1

DSO

- - 782.4 96.2 191.7 - - - - - - -

DIO

- - - - - - - - - - - -

DPO

- - - - - - - - - - - -

Operating Cycle

- - - - - - - - - - - -

Cash Conversion Cycle

- - - - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Marker Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.26 -0.25 -0.27 - -0.34 0.29 -0.57 - -0.83 -1.11 -1.19 - -0.15 -0.13 -0.16 - -0.16 -0.14 -0.14 - -0.12 -0.12 -0.12 - -0.32 -0.41 -0.3 - -0.39 -0.22 -0.29 - -0.29 1.01 -0.81 - 7.04 -1.8 -0.03 - -0.09 0.05 -3.89 - -0.76 -0.87 -0.55 - -0.01 -0.04 -0.01 - -0.02 -0.01 -0.03

EBITDA per Share

- - - - - - -0.4 - -0.46 -0.49 -1.11 - -0.1 -0.12 -0.15 - -0.15 -0.13 -0.14 - -0.12 -0.13 -0.12 - -0.32 -0.39 -0.3 - -0.39 -0.28 -0.29 - -0.37 -0.41 -0.3 - -0.43 -0.03 -0.04 - - - - - -0.25 -0.67 -1.12 - -0.01 -0.05 -0.01 - -0.02 -0.02 -0.02

ROE %

-91.73 -78.59 -42.78 -35.85 -66.46 -79.23 -125.43 -91.36 -115.13 -108.29 -92.55 -53.13 -80.09 -83.27 -89.22 -73.87 -86.25 -71.68 -61.12 -37.08 -44.48 -39.49 -34.97 -20.89 -129.84 -231.40 -275.04 -226.86 -260.86 -185.92 -37.56 -14.21 -147.65 -247.08 -61.77 151.75 304.91 591.51 236.00 2981.68 3005.14 2875.44 2958.98 1004.35 1004.35 1022.98 1055.14 94.08 76.39 100.79 70.39 72.72 24.40 11.69 36.63

ROA %

-72.22 -66.37 -36.13 -21.62 -38.45 -39.98 -69.11 -52.53 -69.81 -70.26 -66.14 -40.77 -56.93 -55.81 -56.16 -44.28 -56.06 -51.67 -49.79 -35.27 -42.33 -37.61 -33.34 -19.95 -96.88 -166.76 -195.56 -160.19 -186.74 -136.36 -24.39 -11.09 417.83 873.30 752.26 337.68 337.68 -45.62 -13281.30 -26471.37 -27842.43 -15977.81 -61920.13 -93255.69 -93255.69 -48853.03 -51763.74 -6506.51 -3843.96 -4092.12 -1300.27 -739.63 -248.16 -118.86 -372.60

ROCE %

- - -18.95 -37.91 -57.44 -58.02 -71.58 -54.05 -69.78 -65.98 -67.00 -40.74 -59.55 -62.63 -64.26 -51.97 -64.71 -58.65 -55.67 -38.69 -46.16 -40.87 -35.51 -20.73 -129.79 -231.38 -288.93 -240.55 -284.56 -219.51 -193.30 -111.58 -103.45 -51.30 -6.76 18.28 18.28 10.14 4.81 - 3.57 7.15 14.85 23.99 37.18 46.79 91.02 76.24 102.39 115.36 83.69 78.22 26.15 20.27 31.80

Current Ratio

3.1 5.9 6.1 5.6 7.0 7.5 2.3 2.3 2.2 2.1 2.9 2.8 3.7 4.7 5.6 2.5 2.5 2.5 2.5 20.4 20.4 20.4 20.4 22.2 22.2 22.2 22.2 3.4 3.4 3.4 3.4 4.6 4.6 4.6 4.6 - - - - - - - - - - - - - - - - - 0.1 0.2 -

DSO

- - - - - - - - - - - - - - - - - 2.7 - - - - - - - 47.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- - - - - - - - - - - - - - - - - 2.7 - - - - - - - 47.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

- - - - - - - - - - - - - - - - - 2.7 - - - - - - - 47.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency